Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

Publication Type:

Journal Article

Source:

Archives of internal medicine, Volume 170, Issue 9, p.765-71 (2010)

Keywords:

2010, Aged, Bone Density, Center-Authored Paper, Female, Fractures, Spontaneous, Humans, Middle Aged, Multivariate Analysis, Osteoporosis, Postmenopause, Proportional Hazards Models, Prospective Studies, Proton Pump Inhibitors, Public Health Sciences Division, Risk Factors, United States

Abstract:

Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. We examined the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]).